Full Coverage
Weight loss: Hims & Hers introduce access to GLP-1 injections
By Julie Hyman
Top news
Heard on the Street: Hims Is Jumping on a Crowded Ozempic Bandwagon
By David Wainer
The Ultimate Growth Stock to Buy With $20 Right Now
By Justin Pope
Online pharmacy to start selling not FDA-approved weight loss drug
By Nancy Chen
Low-Cost GLP-1 Injections
By Michael Hemsworth
All coverage
Hims & Hers announces $199 weight loss shots
By Lucy Brewster
Hims & Hers Is Changing the Game
By Travis Hoium
Hims & Hers Offers Access to GLP-1s Starting At $199 A Month
By Marissa Plescia
Hims Shares Hit 3-Year High After Announcing $199 Weight-Loss Shots
By Antonio Pequeno & Antonio Pequeño IV
Hims & Hers Is Changing the Game
By Travis Hoium
Hims & Hers rallies after launching affordable Wegovy alternatives
By William Farrington
Hims & Hers shares maintain Hold on the expansion of weight loss program
By Natashya Angelica
Hims & Hers, Nestle Enter the GLP-1 Race
By Courtney Rehfeldt
Him & Hers Health Stock Soars After Cheap Weight-Loss Drug Offering
By Ambrose O'callaghan
Hims & Hers expands weight loss program to include access to compounded GLP-1 medications
By Heather Landi
Hims Just Launched an Ozempic Dupe | Inc.com
By Sydney Sladovnik
Hims & Hers Health Inc. Tipping the Scales of the Weight Loss Market — and Wall Street is Loving it!
Hims debuts $199 weight-loss shots at 85% discount to Wegovy
By Madison Muller & Jessica Nix
Is Hims & Hers Stock a Buy for GLP-1 Upside?
By Aditya Raghunath
Hims & Hers Stock Spikes. It’s Taking on Ozempic and Wegovy With Cheap Obesity Shots.
By Karishma Vanjani
Hims & Hers Will Offer Ozempic and Wegovy Alternative Weight-loss Medications That Cost Nearly 90 Percent Less ...
By Hannah Malach
Weight loss drug roll-out sends Hims & Hers stock soaring
By Jamie Ashcroft & Philip Whiterow
Another online pharmacy bypasses the FDA to offer cut-rate weight loss drugs
By Elizabeth Lopatto
Hims & Hers says it's selling a GLP-1 weight loss drug for 85% less than Wegovy. Here's the price.
By Megan Cerullo
Shares of Hims & Hers Health surge 27% after startup says it will offer GLP-1 injections
By Brandon Gomez & Ashley Capoot
